Incannex Healthcare Inc.

IXHL ·Healthcare, Drug Manufacturers - General
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024
Operating Activities
Net Income $-3.9M $-6.5M $-6.4M $-31.6M $-4.0M $-5.9M $-5.4M $-6.5M
Depreciation & Amortization $65.0K $59.0K $66.0K $61.0K $-5.0K $126.0K $64.0K $62.0K
Depreciation $100.0K $-65.9M $66.0M $143.00B $-66.2M $200.0K $66.2M $103.00B
Amortization — — — — — — — —
Stock-Based Compensation $1.5M $2.3M $2.6M $1.3M $417.0K $435.0K $459.0K $3.3M
Net Cash from Operating Activities $-2.5M $-4.6M $-9.2M $-1.5M $-3.2M $-5.6M $-2.2M $-3.6M
Investing Activities
Capital Expenditures $5.0K $4.0K $2.0K — — — — $3.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-18.0K $-4.0K $-42.0K — — — — $-3.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $4.7M $927.0K $67.2M $9.6M $7.7M $4.1M $-52.0K —
Net Change in Cash — — — — — — $-2.2M —
Free Cash Flow $-2.5M $-4.6M $-9.2M — — — — $-3.6M
← Newer Page 1 of 2 Older →